268 related articles for article (PubMed ID: 26966090)
1. An autonomous CEBPA enhancer specific for myeloid-lineage priming and neutrophilic differentiation.
Avellino R; Havermans M; Erpelinck C; Sanders MA; Hoogenboezem R; van de Werken HJ; Rombouts E; van Lom K; van Strien PM; Gebhard C; Rehli M; Pimanda J; Beck D; Erkeland S; Kuiken T; de Looper H; Gröschel S; Touw I; Bindels E; Delwel R
Blood; 2016 Jun; 127(24):2991-3003. PubMed ID: 26966090
[TBL] [Abstract][Full Text] [Related]
2. HoxA9 binds and represses the Cebpa +8 kb enhancer.
Peng L; Guo H; Ma P; Sun Y; Dennison L; Aplan PD; Hess JL; Friedman AD
PLoS One; 2019; 14(5):e0217604. PubMed ID: 31120998
[TBL] [Abstract][Full Text] [Related]
3. In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis.
Guo H; Cooper S; Friedman AD
PLoS One; 2016; 11(3):e0150809. PubMed ID: 26937964
[TBL] [Abstract][Full Text] [Related]
4. The Cebpa +37-kb enhancer directs transgene expression to myeloid progenitors and to long-term hematopoietic stem cells.
Guo H; Ma O; Friedman AD
J Leukoc Biol; 2014 Sep; 96(3):419-26. PubMed ID: 24868087
[TBL] [Abstract][Full Text] [Related]
5. The +37 kb Cebpa Enhancer Is Critical for Cebpa Myeloid Gene Expression and Contains Functional Sites that Bind SCL, GATA2, C/EBPα, PU.1, and Additional Ets Factors.
Cooper S; Guo H; Friedman AD
PLoS One; 2015; 10(5):e0126385. PubMed ID: 25938608
[TBL] [Abstract][Full Text] [Related]
6. Enhancer and Transcription Factor Dynamics during Myeloid Differentiation Reveal an Early Differentiation Block in Cebpa null Progenitors.
Pundhir S; Bratt Lauridsen FK; Schuster MB; Jakobsen JS; Ge Y; Schoof EM; Rapin N; Waage J; Hasemann MS; Porse BT
Cell Rep; 2018 May; 23(9):2744-2757. PubMed ID: 29847803
[TBL] [Abstract][Full Text] [Related]
7. Granulopoiesis requires increased C/EBPα compared to monopoiesis, correlated with elevated Cebpa in immature G-CSF receptor versus M-CSF receptor expressing cells.
Ma O; Hong S; Guo H; Ghiaur G; Friedman AD
PLoS One; 2014; 9(4):e95784. PubMed ID: 24752325
[TBL] [Abstract][Full Text] [Related]
8. CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha.
Koschmieder S; D'Alò F; Radomska H; Schöneich C; Chang JS; Konopleva M; Kobayashi S; Levantini E; Suh N; Di Ruscio A; Voso MT; Watt JC; Santhanam R; Sargin B; Kantarjian H; Andreeff M; Sporn MB; Perrotti D; Berdel WE; Müller-Tidow C; Serve H; Tenen DG
Blood; 2007 Nov; 110(10):3695-705. PubMed ID: 17671235
[TBL] [Abstract][Full Text] [Related]
9. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis.
Guo H; Ma O; Speck NA; Friedman AD
Blood; 2012 May; 119(19):4408-18. PubMed ID: 22451420
[TBL] [Abstract][Full Text] [Related]
10. Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation.
Kandilci A; Grosveld GC
Blood; 2009 Aug; 114(8):1596-606. PubMed ID: 19561324
[TBL] [Abstract][Full Text] [Related]
11. Progression from the Common Lymphoid Progenitor to B/Myeloid PreproB and ProB Precursors during B Lymphopoiesis Requires C/EBPα.
Guo H; Barberi T; Suresh R; Friedman AD
J Immunol; 2018 Sep; 201(6):1692-1704. PubMed ID: 30061199
[TBL] [Abstract][Full Text] [Related]
12. Lineage-instructive function of C/EBPα in multipotent hematopoietic cells and early thymic progenitors.
Wölfler A; Danen-van Oorschot AA; Haanstra JR; Valkhof M; Bodner C; Vroegindeweij E; van Strien P; Novak A; Cupedo T; Touw IP
Blood; 2010 Nov; 116(20):4116-25. PubMed ID: 20807890
[TBL] [Abstract][Full Text] [Related]
13. C/EBPα is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitors.
Hasemann MS; Lauridsen FK; Waage J; Jakobsen JS; Frank AK; Schuster MB; Rapin N; Bagger FO; Hoppe PS; Schroeder T; Porse BT
PLoS Genet; 2014 Jan; 10(1):e1004079. PubMed ID: 24415956
[TBL] [Abstract][Full Text] [Related]
14. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel enhancer of CEBPE essential for granulocytic differentiation.
Shyamsunder P; Shanmugasundaram M; Mayakonda A; Dakle P; Teoh WW; Han L; Kanojia D; Lim MC; Fullwood M; An O; Yang H; Shi J; Hossain MZ; Madan V; Koeffler HP
Blood; 2019 Jun; 133(23):2507-2517. PubMed ID: 30952671
[TBL] [Abstract][Full Text] [Related]
16. C/EBPalpha binds and activates the PU.1 distal enhancer to induce monocyte lineage commitment.
Yeamans C; Wang D; Paz-Priel I; Torbett BE; Tenen DG; Friedman AD
Blood; 2007 Nov; 110(9):3136-42. PubMed ID: 17671233
[TBL] [Abstract][Full Text] [Related]
17. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia.
Pabst T; Mueller BU; Zhang P; Radomska HS; Narravula S; Schnittger S; Behre G; Hiddemann W; Tenen DG
Nat Genet; 2001 Mar; 27(3):263-70. PubMed ID: 11242107
[TBL] [Abstract][Full Text] [Related]
18. EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.
Zjablovskaja P; Kardosova M; Danek P; Angelisova P; Benoukraf T; Wurm AA; Kalina T; Sian S; Balastik M; Delwel R; Brdicka T; Tenen DG; Behre G; Fiore F; Malissen B; Horejsi V; Alberich-Jorda M
Cell Death Differ; 2017 Apr; 24(4):705-716. PubMed ID: 28186500
[TBL] [Abstract][Full Text] [Related]
19. E6AP, an E3 ubiquitin ligase negatively regulates granulopoiesis by targeting transcription factor C/EBPα for ubiquitin-mediated proteasome degradation.
Pal P; Lochab S; Kanaujiya JK; Kapoor I; Sanyal S; Behre G; Trivedi AK
Cell Death Dis; 2013 Apr; 4(4):e590. PubMed ID: 23598402
[TBL] [Abstract][Full Text] [Related]
20. The regulatory control of Cebpa enhancers and silencers in the myeloid and red-blood cell lineages.
Repele A; Krueger S; Bhattacharyya T; Tuineau MY; Manu
PLoS One; 2019; 14(6):e0217580. PubMed ID: 31181110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
